Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
aerosolizedY, againstCoxiella, againstY, airway, Allergan, bacterium, bacteriumYersinia, Black, burnetii, cancer, cellular, China, Circuit, Commonwealth, comparison, consortium, Covidien, Coxiella, cytokine, deterioration, devastating, Developmentfor, dog, Dstl, endemic, epidemic, evolving, exert, fever, Gillette, headed, HPA, hydrocodone, inflammatory, inhaledFrancisella, inhibited, inhibition, intracellular, lipopolysaccharide, longest, Mallinckdrodt, man, microorganism, monolayer, mortality, mouse, murine, negligible, ng, nose, ofY, Overview, pain, path, premature, prove, PurchasePlan, rat, receivedher, resolution, Richmond, Science, Sottera, stay, stimulate, stimulated, stimulation, succumbing, surface, survival, therecognition, thought, tool, traditional, UK, unregulated, unresolved, unstimulated, untreated, VA, vaccine, Virginia, virulent, withC
Filing tables
Filing exhibits
Related press release
ARDMQ similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-148263); and on Form S-8 (No. 333-15947, No. 333-62039, No. 333-92169, No. 333-43152, No. 333-63116, No. 333-85244, No. 333-107157, No. 333-128525, No. 333-135122, No. 333-148226, No. 333-152501, No. 333-161142 and No. 333-169580) and in the related prospectuses, as applicable, of our report dated March 26, 2013, relating to the consolidated financial statements of Aradigm Corporation included in this Annual Report on Form 10-K for the year ended December 31, 2012.
/s/ OUM & Co LLP
San Francisco, California
March 26, 2013